By Drug Target Review2023-12-14T12:00:23
By fusing antigen proteins into an anchor protein, a specific disease could be targeted without the need to purify the antigen.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-18T14:47:08Z
2025-04-22T14:58:00
Sponsored by Takara Bio USA
2023-01-06T10:25:33
Sponsored by Leica Microsystems
2024-01-10T08:23:16
Sponsored by BellBrook Labs
2025-10-08T14:00:00
Sponsored by Eurofins Discovery
2024-02-08T11:07:39
Sponsored by Samplix ApS
2023-09-06T16:55:04
Sponsored by NanoTemper Technologies
Site powered by Webvision Cloud